MICHELLE KIRK: Open Payments
NPI 1356792014 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 20 payments from 10 companies in 2025. Trend: 2023 $253 · 2024 $461 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $67 |
| Lilly USA, LLC | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Novo Nordisk Inc | 2 | $39 |
| Astellas Pharma US Inc | 2 | $36 |
| ABBVIE INC. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| PFIZER INC. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
Products named: GEMTESA, Kerendia, Veozah, MOUNJARO, JARDIANCE, UBRELVY, Ozempic, VOQUEZNA.
Industry payments across KS — which companies pay providers there.
